These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12947084)

  • 1. Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.
    Jendreyko N; Popkov M; Beerli RR; Chung J; McGavern DB; Rader C; Barbas CF
    J Biol Chem; 2003 Nov; 278(48):47812-9. PubMed ID: 12947084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo.
    Jendreyko N; Rader C; Barbas CF; Gaedicke G
    Klin Padiatr; 2006; 218(3):143-51. PubMed ID: 16688670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo.
    Jendreyko N; Popkov M; Rader C; Barbas CF
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8293-8. PubMed ID: 15928093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR).
    Böldicke T; Weber H; Mueller PP; Barleon B; Bernal M
    J Immunol Methods; 2005 May; 300(1-2):146-59. PubMed ID: 15946674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3.
    Jimenez X; Lu D; Brennan L; Persaud K; Liu M; Miao H; Witte L; Zhu Z
    Mol Cancer Ther; 2005 Mar; 4(3):427-34. PubMed ID: 15767551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking translocation of cell surface molecules from the ER to the cell surface by intracellular antibodies targeted to the ER.
    Böldicke T
    J Cell Mol Med; 2007; 11(1):54-70. PubMed ID: 17367501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.
    Tsiamis AC; Morris PN; Marron MB; Brindle NP
    Microvasc Res; 2002 Mar; 63(2):149-58. PubMed ID: 11866538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D; Shen J; Vil MD; Zhang H; Jimenez X; Bohlen P; Witte L; Zhu Z
    J Biol Chem; 2003 Oct; 278(44):43496-507. PubMed ID: 12917408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular antibodies (intrabodies) and their therapeutic potential.
    Lo AS; Zhu Q; Marasco WA
    Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances with ER Targeted Intrabodies.
    Marschall AL; Dübel S; Böldicke T
    Adv Exp Med Biol; 2016; 917():77-93. PubMed ID: 27236553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
    Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    Int J Cancer; 2002 Jan; 97(3):393-9. PubMed ID: 11774295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors.
    Miyazaki Y; Matsunaga S; Tang J; Maeda Y; Nakano M; Philippe RJ; Shibahara M; Liu W; Sato H; Wang L; Nolte RT
    Bioorg Med Chem Lett; 2005 May; 15(9):2203-7. PubMed ID: 15837294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis.
    Wheeler YY; Kute TE; Willingham MC; Chen SY; Sane DC
    FASEB J; 2003 Sep; 17(12):1733-5. PubMed ID: 12958192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells.
    Zheng W; Christensen LP; Tomanek RJ
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2739-45. PubMed ID: 15548727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of functional scFv intrabody to abate the expression of CD147 surface molecule of 293A cells.
    Tragoolpua K; Intasai N; Kasinrerk W; Mai S; Yuan Y; Tayapiwatana C
    BMC Biotechnol; 2008 Jan; 8():5. PubMed ID: 18226275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.
    Müller N; Hartmann C; Genssler S; Koch J; Kinner A; Grez M; Wels WS
    Int J Cancer; 2014 Jun; 134(11):2547-59. PubMed ID: 24243620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2.
    Marron MB; Hughes DP; Edge MD; Forder CL; Brindle NP
    J Biol Chem; 2000 Dec; 275(50):39741-6. PubMed ID: 10995770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
    Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.